The mixed stage health care firm has also closed $54 million toward a $100 million supplemental fund, called Essex Woodlands Health Ventures Fund VIII-A, according to the filing.
The New York-based firm could not immediately be reached for comment.
Investors include the
The new fund is already substantially larger than the $600 million the firm raised in 2006 and Essex Woodlands is putting its money into companies faster than ever before. The firm has invested $90 million in 20 companies so far this year, putting it on pace to do more deals this year than at any point in the firm’s 23-year history, according to data from Thomson Reuters (publisher of PE Week). —Alexander Haislip